These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 16898856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years.
    Tolia V, Johnston G, Stolle J, Lee C.
    Paediatr Drugs; 2004; 6(2):127-31. PubMed ID: 15035653
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A, Propst T, Judmaier G.
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [Abstract] [Full Text] [Related]

  • 4. Ranitidine effervescent and famotidine wafer in the relief of episodic symptoms of gastro-oesophageal reflux disease.
    Engzelius JM, Solhaug JH, Knapstad LJ, Kjaersgaard P.
    Scand J Gastroenterol; 1997 Jun; 32(6):513-8. PubMed ID: 9200279
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Taste comparisons for lansoprazole strawberry-flavoured delayed-release orally disintegrating tablet and ranitidine peppermint-flavoured syrup in children.
    Tolia V, Han C, North JD, Amer F.
    Clin Drug Investig; 2005 Jun; 25(5):285-92. PubMed ID: 17532666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Bioequivalence and bioavailability after single administration of effervescent ranitidine tablets].
    Hartmann B, Schmieder G, Tetzloff W, Töberich H.
    Arzneimittelforschung; 1992 Aug; 42(8):1020-2. PubMed ID: 1418073
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 11. On-demand therapy in gastroesophageal reflux disease: a comparison of the early effects of single doses of fast-dissolving famotidine wafers and ranitidine tablets.
    Johannessen T, Kristensen P.
    Clin Ther; 1997 Mar; 19(1):73-81. PubMed ID: 9083710
    [Abstract] [Full Text] [Related]

  • 12. Time to relief of episodic symptoms of gastro-oesophageal reflux disease. A crossover comparison of single doses of the effervescent and standard formulations of ranitidine.
    Elm M, Hellke P, Andrén K, Dahl G, Nyth AL.
    Scand J Gastroenterol; 1998 Sep; 33(9):900-4. PubMed ID: 9759942
    [Abstract] [Full Text] [Related]

  • 13. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
    Pipkin GA, Mills JG.
    Scand J Gastroenterol Suppl; 1999 Sep; 230():3-8. PubMed ID: 10499455
    [Abstract] [Full Text] [Related]

  • 14. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R, García-Gea C, Puntes M, Pérez J, Esbrí R, Serra C, Fortea J, Barbanoj MJ.
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and bioequivalence study of ranitidine film tablets in healthy male subjects.
    Gschwend MH, Guserle R, Erenmemişoglu A, Martin W, Tamur U, Kanzik I, Hincal AA.
    Arzneimittelforschung; 2007 May; 57(6):315-9. PubMed ID: 17688076
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.
    Florian J, Matta MK, DePalma R, Gershuny V, Patel V, Hsiao CH, Zusterzeel R, Rouse R, Prentice K, Nalepinski CG, Kim I, Yi S, Zhao L, Yoon M, Selaya S, Keire D, Korvick J, Strauss DG.
    JAMA; 2021 Jul 20; 326(3):240-249. PubMed ID: 34180947
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Formulation, characterization and physicochemical evaluation of ranitidine effervescent tablets.
    Aslani A, Jahangiri H.
    Adv Pharm Bull; 2013 Jul 20; 3(2):315-22. PubMed ID: 24312854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.